Phosphodiesterase 5 inhibitors in male sexual dysfunction.
about
Current use of phosphodiesterase inhibitors in urologyThalamus and penile erection.Potency and selectivity of vardenafil: a phosphodiesterase Type 5 inhibitor.Molecular mechanisms that could contribute to prolonged effectiveness of PDE5 inhibitors to improve erectile function.Penile rehabilitation: the evolutionary concept in the management of erectile dysfunction.Lack of erectogenic activity of a novel selective melanocortin-4 receptor agonist in a clinical experimental model.
P2860
Phosphodiesterase 5 inhibitors in male sexual dysfunction.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Phosphodiesterase 5 inhibitors in male sexual dysfunction.
@ast
Phosphodiesterase 5 inhibitors in male sexual dysfunction.
@en
type
label
Phosphodiesterase 5 inhibitors in male sexual dysfunction.
@ast
Phosphodiesterase 5 inhibitors in male sexual dysfunction.
@en
prefLabel
Phosphodiesterase 5 inhibitors in male sexual dysfunction.
@ast
Phosphodiesterase 5 inhibitors in male sexual dysfunction.
@en
P1476
Phosphodiesterase 5 inhibitors in male sexual dysfunction.
@en
P2093
Andrea Kuthe
P304
P356
10.1097/00042307-200309000-00008
P577
2003-09-01T00:00:00Z